- $3.40bn
- $4.07bn
- $1.62bn
- 85
- 19
- 97
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,154 | 1,072 | 1,315 | 1,430 | 1,617 |
Cost of Revenue | |||||
Gross Profit | 261 | 214 | 314 | 289 | 343 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,084 | 1,032 | 1,239 | 1,384 | 1,518 |
Operating Profit | 69.9 | 39.7 | 76.5 | 45.6 | 98.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 29.7 | -0.854 | 58.9 | 43 | 38.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 23.4 | -1.75 | 36.6 | 33.6 | 30.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 14.8 | -14.8 | 24.7 | 10.7 | 3.04 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 14.8 | -14.8 | 24.7 | 10.7 | 3.04 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.376 | -0.555 | 0.559 | 0.286 | 0.029 |